NLRP3 and Crohn disease: While this was not shown to be explicitly NLRP3 dependent, it is reasonable to speculate given that one study has demonstrated hyperactivation of NLRP3 in Crohn’s Disease patients (60%) as compared to healthy controls (28.6%) (64).